The path to #raredisease product innovation involves interdependencies between clinical, regulatory, and commercial. Understanding these and the challenges along the way is integral to successfully bringing these therapies to #patients in need. PharmaLex' Dr. Christian K Schneider engages experts in a conversation on the considerations. https://lnkd.in/eigstFFW
pharmaphorum
Media Production
West Byfleet, Surrey 10,153 followers
Industry leading publications, strategic consulting and a content-driven stakeholder engagement agency
About us
pharmaphorum.com, and its associated digital magazine Deep Dive, is a leading online destination for healthcare and pharmaceutical industry news, insight and debate. www.pharmaphorum.com
- Website
-
https://pharmaphorum.com/about/
External link for pharmaphorum
- Industry
- Media Production
- Company size
- 11-50 employees
- Headquarters
- West Byfleet, Surrey
- Type
- Privately Held
- Founded
- 2009
- Specialties
- pharmaceuticals, media, biotech, networking, marketing, sales, R&D, devices, diagnostics, commercial, content, communications, creative, consulting, publishing, market access, patients, digital health, and oncology
Locations
-
Primary
Get directions
Rosemount House
Rosemount Avenue
West Byfleet, Surrey KT14 6LB, GB
Employees at pharmaphorum
Updates
-
NEWS: Natural killer #celltherapy specialist Artiva Biotherapeutics has another go at an IPO, hoping to raise up to $135m for lead candidate AlloNK for autoimmune diseases including #lupus https://bit.ly/3zJm7p4
Artiva announces terms for its second IPO attempt
pharmaphorum.com
-
NEWS: . @NovoHoldings leads $100m financing for Swiss #biotech Asceneuron SA, which is developing an oral #tau therapy for #Alzheimers disease https://bit.ly/465zvjf
Novo leads $100m financing for Alzheimer's player Asceneuron
pharmaphorum.com
-
NEWS: A digital diagnostic for #ADHD called QbTest should be used by @NHSEngland as an add-on to standard assessment, says new @NICEcomms guidance https://bit.ly/4cEa6Qr
-
NEWS: Framework governing early-stage #clinicaltrials in the UK is stifling research and needs to be simplified, says @BritJClinPharm paper https://bit.ly/3y67xr2
Call goes out for simpler clinical trial regulation in UK
pharmaphorum.com
-
NEWS: Lexeo Therapeutics' #genetherapy for Friedreich's ataxia shows promise in clinical trial, but investors may need more convincing $LXEO #CureFA https://bit.ly/4bMNaNB
Lexeo therapy gives hope to Friedreich's ataxia patients
pharmaphorum.com
-
Did you miss our one-hour fireside chat about FDA's new #PDURS framework for drug comparison software labelling? Don't worry - the conversation with Marty Culjat, VP, global head of digital medicine and regulatory innovation at EVERSANA and Edward Cox, head & general manager of Digital Health & Medicines (DHM) at Pfizer is available on-demand, full of insights and best practices on how to position yourself for this upcoming sea of change in #digital health for #pharma https://lnkd.in/e4e8Vdyt
PDURS explained: The FDA’s new framework for adding software to drug labels
pharmaphorum.com
-
NEWS: Two investment funds have decided to contest Taisho Pharma's recently announced management buyout plan in court #pharma #consumerhealthcare https://lnkd.in/eGyYbMFZ
Investors take issue with Taisho Pharma’s buyout price
pharmaphorum.com
-
Pharma #medicalwriting is an onerous, ongoing activity that could benefit hugely from tech-enabled disruption, and the latest advances in generative AI (#GenAI) show promise in alleviating the pain. Celegence's Punya Abbhi discusses. https://lnkd.in/e7vSeenT
How is the rise of GenAI changing the field of pharma medical writing?
pharmaphorum.com